EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours-Reference-Cited by-同舟云学术

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

Published:2006-10 Issue:15 Volume:42 Page:2433-2453
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Aapro M.S.,Cameron D.A.,Pettengell R.,Bohlius J.,Crawford J.,Ellis M.,Kearney N.,Lyman G.H.,Tjan-Heijnen V.C.,Walewski J.,Weber D.C.,Zielinski C.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference155 articles.

1. Incidence and predictors of low dose-intensity in adjuvant breast cancer chemotherapy: a nationwide study of community practices;Lyman;J Clin Oncol,2003

2. Risk of febrile neutropenia among patients with intermediate-grade non-Hodgkin’s lymphoma receiving CHOP chemotherapy;Lyman;Leuk Lymphoma,2003

3. Risk of neutropenic complications based on a prospective nationwide registry of cancer patients initiating systematic chemotherapy;Wolff;Proc Am Soc Clin Oncol,2004

4. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-Hodgkin lymphoma;Lyman;Cancer,2003

5. First and subsequent cycle use of pegfilgrastim prevents febrile neutropenia in patients with breast cancer: a multicenter, double-blind, placebo-controlled phase III study;Vogel;J Clin Oncol,2005

Cited by 474 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost of Pegfilgrastim for the Prophylaxis of Chemotherapy-induced Febrile Neutropenia in Patients with Breast Cancer Receiving Perioperative Chemotherapy in Daily Practice in Japan: A Posthoc Analysis in a Single-center Retrospective Study;YAKUGAKU ZASSHI;2024-09-01

2. Genetic susceptibility to breast cancer increases the risk of neutropenia and agranulocytosis: insights from Mendelian randomization;Supportive Care in Cancer;2024-06-29

3. Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF 2022;International Journal of Clinical Oncology;2024-06-20

4. Effect of lithium on chemotherapy-induced neutropenia in Egyptian breast cancer patients; a prospective clinical study;Cancer Chemotherapy and Pharmacology;2024-02-07

5. Role of biosimilar pegfilgrastim in the treatment of febrile neutropenia: A Mini Review;Indian Journal of Biochemistry and Biophysics;2024